Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

BIZARRE: Benzinga s top ratings upgrades downgrades for july 26 2022 - What They Never Told You

Upgrades

For Agile Therapeutics Inc (NASDAQ:AGRX), Maxim Group upgraded the previous rating of Hold to Buy. For the first quarter, Agile Therapeutics had an EPS of $3.78, compared to year-ago quarter EPS of $8.00. The stock has a 52-week-high of $4.37 and a 52-week-low of $0.11. At the end of the last trading period, Agile Therapeutics closed at $0.50.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.